|
|
||||||||
Address correspondence to Bahri Ermis, M.D., Department of Pediatrics, School of Medicine, Zonguldak Karaelmas University, 67600 Kozlu/Zonguldak, Turkey; tel 90 372 261 0169; fax 90 372 261 0155; e-mail bahriermis{at}yahoo.com.
| Abstract |
|---|
|
|
|---|
Keywords: smoking, pregnancy, newborns, malondialdehyde, glutathione peroxidase, superoxide dysmutase
| Introduction |
|---|
|
|
|---|
Cigarette smoking has been suggested as a source of oxidant stress in pregnant women and their infants exposed in utero. It has been demonstrated that antioxidant vitamin concentrations are lower in smokers than in non-smokers, which could be due either to an inadequate diet or an inadequate intake of antioxidants in smokers [4]. The deficiency of antioxidant vitamins may also promote oxidative stress.
In the English literature, there is only one study of plasma antioxidant vitamin status of mothers and their newborns at delivery and in the immediate neonatal period in relation to maternal smoking [5]. Serum superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, which are the important components of the antioxidant systems in the body, have not been studied until now.
The aim of this study was to evaluate the levels of serum malondialdehyde (MDA), SOD, and GPx in mothers and their infants in relation to maternal smoking during pregnancy.
| Materials and Methods |
|---|
|
|
|---|
Based on interviews and birth records, 43 mothers and their infants met the eligibility criteria and were classified into 1 of 3 groups: (a) the active-smoking group (n = 14) in which both the mother (510 cigarettes/day in pregnancy) and father (20 cigarettes/day) had been smoking up to date; (b) the passive-smoking group (n = 14) in which only the father (20 cigarettes/day) had been smoking in the house; and (c) the non-smoking group (n = 15) in which the parents never smoked either before or during pregnancy.
Inclusion criteria. The following criteria were used to accept the mothers and their infants into the study: no maternal chronic illness, no alcohol consumption, no gestational problems (eg, hypertension, preeclampsia, diabetes mellitus, or infection), no congenital anomalies, no neonatal complications (asphyxia, meconium aspiration, etc), no intrauterine growth retardation, no caesarean section, no jaundice requiring phototherapy, no formula feeding, birth weight >2500 g, and gestational age >37 weeks.
Biochemical assays. Venous blood samples were collected in Vacutainer tubes without any additive and were centrifuged at 3500 x g (5 min, 4°C). Serum aliquots were immediately stored at 80°C until the biochemical analyses were performed. All chemicals and reagents were obtained from Sigma Chemical Co (St Louis, MO, USA). Spectrophotometric measurements were performed using a model DU 530 spectrophotometer (Beckman Instruments, Brea, CA, USA).
Malondialdehyde (MDA) assay. MDA, a product of lipid peroxidation, was determined spectrophotometrically by a method similar to that described by Jain et al [6]. Briefly, 0.2 ml of serum was mixed thoroughly with 0.8 ml of phosphate buffered saline (pH 7.4) and 0.025 ml of butylated hydroxytoluene solution (8.8 g/L). After addition of 0.5 ml of 30% trichloroacetic acid, the samples were placed on ice for 2 hr and then centrifuged at 2000 x g for 15 min. One ml of supernatant was mixed with 0.075 ml of 0.1 M EDTA and 0.25 ml of 1% thiobarbituric acid in 0.05 N NaOH. The samples were placed in boiling water for 15 min, cooled to room temperature, and the absorbance was determined at 532 nm. Total thiobarbutiric acid reactive substances were expressed as MDA, using molar extinction coefficient for MDA of 1.56 x 105 cm1 · M·1. The results were expressed as µmol/L.
Superoxide dismutase (SOD) assay. CuZn-superoxide dismutase (SOD) activity was detected by the method of Sun et al [7]. Exactly 2.45 ml of assay reagent (containing 0.3 mM xanthine, 0.6 mM Na2EDTA, 0.15 mM nitroblue tetrazolium (NBT), 0.4 M Na2CO3, 1 g/l bovine serum albumin) was combined with 100 µl of serum sample. Xanthine oxidase (50 µl, 167 U/L) was added to initiate the reaction and the reduction of NBT by superoxide anion radicals, which are produced by the xanthine-xanthine oxidase system, was determined by measuring the absorbance at 560 nm. CuZn-SOD activity was expressed in units of SOD per liter, where 1 U is defined as that amount of enzyme causing half-maximal inhibition of NBT reduction.
Glutathione peroxidase (GPx) assay. GPx activity was measured by the method of Paglia and Valentine [8]. To a 0.5 mL serum sample, an equal volume of double strength Drabkins reagent was added and mixed. This mixture (50 µl) was combined with 100 µl of 8 mM NADPH, 100 ml of 150 mM glutathione (reduced form), 20 ml of glutathione reductase (30 U/ml), 20 µl of 0.12 M sodium azide solution, and 2.65 ml of 50 mM potassium phosphate buffer (pH 7.0, 5 mM EDTA) and the tubes incubated for 30 min at 37°C. The reaction was initiated with the addition of 100 µl of 2 mM H2O2 solution, mixed rapidly by inversion, and the conversion of NADPH to NADP was measured spectrophotometrically for 5 min at 340 nm. The enzyme activity was expressed as U/L.
Statistical analysis.
All data were entered into an SPSS database (SPSS Inc, Chicago, IL, USA). Nonparametric tests were used due to the small number of the groups. The significance of the differences among the 3 groups was evaluated by Kruskal-Wallis one-way analysis. When the p value was <0.05, it was considered a statistically significant difference among the 3 groups. For comparisons between 2 groups, the Mann-Whitney U test was used, and p values smaller than 0.016 (<0.05/3) were considered to show a significant difference. The chi-square (
2) test was also used where appropriate.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Pregnancy is a physiological state accompanied by high metabolic demand and elevated requirements for tissue oxygen, resulting in over-production of reactive oxygen species and lipid peroxidation [3]. The antioxidative defense system is modified during pregnancy to limit oxidative stress [3].
In our study, we investigated serum levels of MDA, SOD, and GPx in active-smoking, passive-smoking and non-smoking mothers and their newborns. Because the process of labor itself may be associated with production of oxygen free radicals, we evaluated antioxidant status at 7 days after delivery. We did not find any significant differences among the study groups with respect to MDA and SOD levels in either mothers or infants. However, serum mean SOD activities seem to be lower in infants in the smoking group than in the others, suggesting an oxidative stress. On the other hand, there were significant differences among the study groups with respect to serum GPx activities in the mothers (p = 0.028) and the infants (p = 0.039). When GPx activities were analyzed separately in both mothers and infants, a significant difference was noted only between the infants of smoking vs non-smoking groups (p = 0.015).
There are a few studies suggesting that cigarette smoking is a source of oxidant stress in pregnant women and their newborns. Smoking even a single cigarette may cause transient uteroplacental vasoconstriction [3]. Placental glutathione uptake is decreased in pregnant smokers, resulting in reduction of fetal glutathione levels [3]. Schwarz et al [16] showed that the breath ethane test, which is an indicator of oxidant stress, is increased in both pregnant smokers and in infants of smoking mothers compared to non-smoking controls. Vitamin E levels are lower in tissues of smokers than in non-smokers. Infants of smoking mothers have low vitamin E levels, consistent with neonatal oxidative stress [5].
In mothers and newborns, the most detailed study of plasma MDA and antioxidant vitamin status was carried out by Bolisetty et al [5]. In that study, although the mean plasma MDA levels were higher at delivery than in the immediate postnatal period in both mothers and infants, no significant differences were observed between smoking and non-smoking groups with respect to MDA, as confirmed by our study. The increased levels of MDA seen at delivery were attributed to increased oxidative stress during labor and delivery. They found that plasma vitamin E levels were lower in smokers than in non-smokers in both mothers and newborns. These results suggest an increased oxidative stress in the smoking group, resulting in increased consumption of vitamin E. In contrast to the Bolisetty study [5], we assayed serum activities of SOD and GPx, which are major components of the bodys antioxidant defense system.
Sajjad et al [17] compared the cord blood activities of SOD and GPx between spontaneous vaginal delivery and cesarean section cases, and they found increased GPx and decreased SOD activities in normal vaginal deliveries compared to cesarean sections. They claimed that the fetus responds to the oxidative stress by increasing its GPx activity. Also, increased utilization of SOD may explain the low values of SOD in normal vaginal deliveries compared to cesarean sections. Initially, these results may appear inconsistent. However, GPx is responsible for removing lipoperoxidation products, which are formed over a longer period, whereas SOD is responsible for removing oxygen free radicals which occur over a short period of time [17]. GPx limits the accumulation of lipid peroxides and utilizes glutathione as its cofactor to convert lipid peroxides into less harmful substances.
In conclusion, there was significant increase in serum GPx activities of smoking mothers and their infants, suggesting that they may have been exposed to more oxidant stress than non-smoking mothers and their infants.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. Basyigit, M. Tugay, M.O. Dilioglugil, F. Yildiz, H. Maral, and S. Sozubir Protective effects of N-acetylcysteine on peroxidative changes of the fetal rat lungs whose mothers were exposed to cigarette smoke Human and Experimental Toxicology, February 1, 2007; 26(2): 99 - 103. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |